Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,971,921
New position
Shares Held
695,392
first reported quarter
Ownership
0.244%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $91,176,029 across 18 Diagnostics & Research names. SHC ranks #2 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
41,135 | $19,752,615 | |
| 2 | SHC |
Sotera Health Co
This page
|
695,392 | $9,971,921 | |
| 3 | A |
Agilent Technologies, Inc.
|
73,689 | $8,399,072 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
47,119 | $8,035,674 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
14,487 | $7,120,795 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
5,138 | $6,480,045 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
10,314 | $5,795,333 | |
| 8 | NTRA |
Natera, Inc.
|
25,237 | $5,047,147 |
All Filings in SHC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,971,921 | 695,392 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||